Beginnings of Personalized Medicine for Myeloma

Ajai Chari, MD

Video Categories: Personalized Medicine

Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.
September 2, 2015

Challenges with Oral Oncolytics for Payers and Practice Managers

Dixie-Lee Esseltine, MD and George Mulligan, PhD shed light on the challenges that payers and practice managers will face as more oncolytics come into the market.

January 30, 2014

Personalized Medicine and the Impact on the Pharmaceutical Company

Dr Agarwala hypothesizes how the future of the traditional pharmaceutical company may change with the developments in personalized medicine.